Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors. (Q38876214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

review article

1 reference

title

Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

Cinnabarinic acid

31 May 2024

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Martina Curto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

Valeria Maria Gloria Bruno

15 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Giuseppe Battaglia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

10

Ferdinando Nicoletti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

Luana Lionetto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Luisa Iacovelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Caroline S Copeland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Stuart A Neale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Thomas E Salt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

publication date

21 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

Pt B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

365-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.

15 March 2020

cites work

2 references

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PONE.0087877

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Enzymic conversion of 3-hydroxyanthranilic acid into cinnabarinic acid. Partial purification and properties of ra-liver cinnabarinate synthase

2 references

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1042/BJ0990317

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors

2 references

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1124/MOL.111.074765

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Kynurenines and vitamin B6: link between diabetes and depression

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Kynurenine 3-monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Kynurenines in the mammalian brain: when physiology meets pathology

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Correction for Han et al., "Biochemical and Structural Properties of Mouse Kynurenine Aminotransferase III".

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.

2 references

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.NEUROPHARM.2014.02.011

Imbalanced kynurenine pathway in schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells

2 references

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

31 May 2024

https://opencitations.net/index/api/v1/citations/10.4049/JIMMUNOL.0903670

The aryl hydrocarbon receptor in immunity

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

The analgesic effects of tryptophan and its metabolites in the rat

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Xanthurenic acid induces gametogenesis in Plasmodium, the malaria parasite

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Identification of a serotonin/glutamate receptor complex implicated in psychosis

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

3-hydroxykynurenine transamination leads to the formation of the fluorescent substances in human lenses

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

The two faces of the pharmacological interaction of mGlu2 and 5-HT₂A - relevance of receptor heterocomplexes and interaction through functional brain pathways

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

The aryl hydrocarbon receptor: a perspective on potential roles in the immune system

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Metabotropic glutamate receptors as drug targets: what's new?

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Identification of xanthurenic acid 8-O-beta-D-glucoside and xanthurenic acid 8-O-sulfate as human natriuretic hormones

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Altered serum levels of kynurenine metabolites in patients affected by cluster headache

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Xanthurenic acid translocates proapoptotic Bcl-2 family proteins into mitochondria and impairs mitochondrial function

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Oxidation of 3-hydroxyanthranilic acid to the phenoxazinone cinnabarinic acid by peroxyl radicals and by compound I of peroxidases or catalase

2 references

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1021/BI00149A045

The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Actions of Xanthurenic acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Xanthurenic acid distribution, transport, accumulation and release in the rat brain.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR).

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Xanthurenic acid binds to neuronal G-protein-coupled receptors that secondarily activate cationic channels in the cell line NCB-20

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Aryl hydrocarbon receptor ligand effects in RBL2H3 cells

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

AhR: far more than an environmental sensor

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Metabotropic glutamate receptors and the control of chronic pain

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Targeting metabotropic glutamate receptors in neuroimmune communication

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Development of allosteric modulators of GPCRs for treatment of CNS disorders

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Laccase-catalyzed formation of cinnabarinic acid is responsible for antibacterial activity of Pycnoporus cinnabarinus

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Metabotropic glutamate receptors: from the workbench to the bedside

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Aryl hydrocarbon receptor-dependent stanniocalcin 2 induction by cinnabarinic acid provides cytoprotection against endoplasmic reticulum and oxidative stress

1 reference

31 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROPHARM.2016.06.020

Identifiers

DOI

10.1016/J.NEUROPHARM.2016.06.020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27342123%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference